148 related articles for article (PubMed ID: 8543166)
1. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA
Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166
[TBL] [Abstract][Full Text] [Related]
2. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
Anazodo MI; Wainberg MA; Friesen AD; Wright JA
J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioate.
Anazodo MI; Wainberg MA; Friesen AD; Wright JA
Leukemia; 1995 Oct; 9 Suppl 1():S86-8. PubMed ID: 7475322
[TBL] [Abstract][Full Text] [Related]
4. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
5. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
Zelphati O; Zon G; Leserman L
Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
8. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
[TBL] [Abstract][Full Text] [Related]
10. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
[TBL] [Abstract][Full Text] [Related]
12. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC
AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
14. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.
Veres G; Junker U; Baker J; Barske C; Kalfoglou C; Ilves H; Escaich S; Kaneshima H; Böhnlein E
J Virol; 1998 Mar; 72(3):1894-901. PubMed ID: 9499041
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
Boulme F; Perälä-Heape M; Sarih-Cottin L; Litvak S
Biochim Biophys Acta; 1997 Apr; 1351(3):249-55. PubMed ID: 9130587
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
[TBL] [Abstract][Full Text] [Related]
18. A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
Kinchington D; Galpin S; Jaroszewski JW; Ghosh K; Subasinghe C; Cohen JS
Antiviral Res; 1992 Jan; 17(1):53-62. PubMed ID: 1736810
[TBL] [Abstract][Full Text] [Related]
19. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]